For: | Wu H, Sun HC, Ouyang GF. T-cell immunoglobulin mucin molecule-3, transformation growth factor β, and chemokine-12 and the prognostic status of diffuse large B-cell lymphoma. World J Clin Cases 2022; 10(32): 11804-11811 [PMID: 36405294 DOI: 10.12998/wjcc.v10.i32.11804] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i32/11804.htm |
Number | Citing Articles |
1 |
Aaron Tsumura, Daniel Levis, Joseph M. Tuscano. Checkpoint inhibition in hematologic malignancies. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1288172
|
2 |
Wenyue Sun, Shunfeng Hu, Xin Wang. Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies. Cancer Communications 2024; 44(9): 1071 doi: 10.1002/cac2.12587
|
3 |
Qiqi Zhu, Yiming Yang, Kexin Chen, Qiaoyu Zhang, Yifan Huang, Shunhai Jian. Diffuse large B-cell lymphoma: the significance of CD8+ tumor-infiltrating lymphocytes exhaustion mediated by TIM3/Galectin-9 pathway. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05002-3
|
4 |
Tian-long Wang, Xiao-juan Miao, Yan-rong Shuai, Hao-ping Sun, Xiao Wang, Min Yang, Nan Zhang. FAT1 inhibits the proliferation of DLBCL cells via increasing the m6A modification of YAP1 mRNA. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-62793-7
|